BCDA vs CFLT · $14.4M cap vs rev $963.6M
Biocardia Inc (BCDA) versus Confluent Inc (CFLT) — a side-by-side from cached financials, not a winner call.
Biocardia Inc (BCDA) is a biotechnology company listed on NASDAQ.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
BCDA does not have a complete income-statement cache yet.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
BCDA currently screens at market cap $14.4M. CFLT currently screens at market cap $11.13B.
Not investment advice. Open the BCDA and CFLT stock pages for the full models.
Not investment advice.